查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1556595

慢性鼻竇市場報告：2030 年趨勢、預測與競爭分析

Chronic Rhinosinusitis Market Report: Trends, Forecast and Competitive Analysis to 2030
出版日期: | 出版商: Lucintel | 英文 150 Pages | 商品交期: 3個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

簡介目錄

鼻竇趨勢和預測

預計 2024 年至 2030 年，全球鼻竇市場將以 7.5% 的複合年成長率成長。該市場的主要驅動力是臨床試驗數量的增加、對創新治療方法的需求不斷成長以及診斷工具的不斷技術進步。全球慢性鼻竇市場的未來充滿希望，醫院、專科診所和門診手術中心市場充滿機會。

慢性鼻竇依部位分類

本研究按治療類型、疾病表現型、最終用途和地區提供了慢性鼻竇的全球估計。

慢性鼻竇市場洞察

Lucintel 預測類固醇滴鼻劑將在預測期內達到最高成長。

在這個市場中，預計醫院將在預測期內呈現最高的成長。

預計北美地區在預測期內將出現最高的成長。

常問問題

Q1.市場成長預測是多少：

A1. 2024年至2030年，全球鼻竇市場預計將以7.5%的複合年成長率成長。

Q2. 影響市場成長的關鍵促進因素是：

A2. 慢性鼻竇市場的主要驅動力是臨床試驗數量的增加、對創新治療方法的需求不斷成長以及診斷工具的持續技術進步。

Q3.市場的主要細分市場是：

A3. 慢性鼻竇市場的未來前景廣闊，醫院、專科診所和門診手術中心市場充滿機會。

Q4.市場的主要企業是：

A4. 慢性鼻竇的一些主要企業如下：

  • Lyra Therapeutics
  • Novartis
  • Medtronic
  • GlaxoSmithKline
  • AstraZeneca
  • Sanofi
  • Dr. Reddy's Laboratories
  • Stryker Corporation
  • Bayer
  • Smith & Nephew

Q5.未來最大的細分市場是什麼？

A5.Lucintel 預測類固醇滴鼻劑將在預測期內出現最高成長。

Q6.未來五年預計哪些地區的市場成長最大？

A6. 預計北美地區在預測期內將出現最高成長。

Q7. 可以客製化報告嗎？

A7。

目錄

第1章執行摘要

第2章全球慢性鼻竇市場：市場動態

  • 簡介、背景、分類
  • 供應鏈
  • 產業促進因素與挑戰

第3章 2018-2030年市場趨勢及預測分析

  • 宏觀經濟趨勢（2018-2023）與預測（2024-2030）
  • 慢性鼻竇的全球市場趨勢（2018-2023）和預測（2024-2030）
  • 按治療類型分類的全球慢性鼻竇市場
    • 醫療設備
    • 藥物
    • 滴鼻劑
    • 類固醇滴鼻劑
    • 外科手術
    • 其他
  • 按疾病表現型分類的全球慢性鼻竇市場
    • 非嗜酸性粒細胞性慢性鼻竇
    • 嗜酸性粒細胞慢性鼻竇
    • 傳染性慢性鼻竇
    • 過敏性黴菌性鼻竇
    • 其他
  • 按最終用途分類的慢性鼻竇市場規模
    • 醫院
    • 專科診所
    • 門診手術中心
    • 其他

第4章 2018-2030年區域市場趨勢及預測分析

  • 按地區分類的全球慢性鼻竇市場
  • 北美慢性鼻竇市場
  • 歐洲慢性鼻竇市場
  • 亞太地區慢性鼻竇市場
  • 其他區域慢性鼻竇市場

第5章 競爭分析

  • 產品系列分析
  • 營運整合
  • 波特五力分析

第6章 成長機會與策略分析

  • 成長機會分析
    • 按治療類型分類的全球慢性鼻竇市場成長機會
    • 按疾病表現型分類的全球慢性鼻竇市場成長機會
    • 全球鼻竇市場最終用途的成長機會
    • 全球慢性鼻竇市場成長機會（按地區）
  • 全球慢性鼻竇市場的新興趨勢
  • 戰略分析
    • 新產品開發
    • 全球慢性鼻竇市場的產能擴張
    • 全球鼻竇市場的合併、收購和合資企業
    • 認證和許可

第7章主要企業概況

  • Lyra Therapeutics
  • Novartis
  • Medtronic
  • GlaxoSmithKline
  • AstraZeneca
  • Sanofi
  • Dr. Reddy's Laboratories
  • Stryker Corporation
  • Bayer
  • Smith & Nephew
簡介目錄

Chronic Rhinosinusitis Trends and Forecast

The future of the global chronic rhinosinusitis market looks promising with opportunities in the hospital, specialty clinic, and ambulatory surgical center markets. The global chronic rhinosinusitis market is expected to grow with a CAGR of 7.5% from 2024 to 2030. The major drivers for this market are growing number of clinical trials, rise in the need for innovative therapeutic approaches, and ongoing technological advancements in diagnostic tools.

A more than 150-page report is developed to help in your business decisions. Sample figures with some insights are shown below.

Chronic Rhinosinusitis by Segment

The study includes a forecast for the global chronic rhinosinusitis by treatment type, disease phenotype, end use, and region.

Chronic Rhinosinusitis Market by Treatment Type [Shipment Analysis by Value from 2018 to 2030]:

  • Medical Devices
  • Drugs
  • Nasal Drops
  • Steroid Nasal Sprays
  • Surgery
  • Others

Chronic Rhinosinusitis Market by Disease Phenotype [Shipment Analysis by Value from 2018 to 2030]:

  • Non-Eosinophilic Chronic Rhinosinusitis
  • Eosinophilic Chronic Rhinosinusitis
  • Infectious Chronic Rhinosinusitis
  • Allergic Fungal Rhinosinusitis
  • Others

Chronic Rhinosinusitis Market by End Use [Shipment Analysis by Value from 2018 to 2030]:

  • Hospitals
  • Specialty Clinics
  • Ambulatory Surgical Centers
  • Others

Chronic Rhinosinusitis Market by Region [Shipment Analysis by Value from 2018 to 2030]:

  • North America
  • Europe
  • Asia Pacific
  • The Rest of the World

List of Chronic Rhinosinusitis Companies

Companies in the market compete on the basis of product quality offered. Major players in this market focus on expanding their manufacturing facilities, R&D investments, infrastructural development, and leverage integration opportunities across the value chain. With these strategies chronic rhinosinusitis companies cater increasing demand, ensure competitive effectiveness, develop innovative products & technologies, reduce production costs, and expand their customer base. Some of the chronic rhinosinusitis companies profiled in this report include-

  • Lyra Therapeutics
  • Novartis
  • Medtronic
  • GlaxoSmithKline
  • AstraZeneca
  • Sanofi
  • Dr. Reddy's Laboratories
  • Stryker Corporation
  • Bayer
  • Smith & Nephew

Chronic Rhinosinusitis Market Insights

Lucintel forecasts that steroid nasal spray is expected to witness the highest growth over the forecast period.

Within this market, hospital is expected to witness the highest growth over the forecast period.

North America is expected to witness the highest growth over the forecast period.

Features of the Global Chronic Rhinosinusitis Market

Market Size Estimates: Chronic rhinosinusitis market size estimation in terms of value ($B).

Trend and Forecast Analysis: Market trends (2018 to 2023) and forecast (2024 to 2030) by various segments and regions.

Segmentation Analysis: Chronic rhinosinusitis market size by treatment type, disease phenotype, end use, and region in terms of value ($B).

Regional Analysis: Chronic rhinosinusitis market breakdown by North America, Europe, Asia Pacific, and Rest of the World.

Growth Opportunities: Analysis of growth opportunities in different treatment types, disease phenotypes, end uses, and regions for the chronic rhinosinusitis market.

Strategic Analysis: This includes M&A, new product development, and competitive landscape of the chronic rhinosinusitis market.

Analysis of competitive intensity of the industry based on Porter's Five Forces model.

FAQ

Q1. What is the growth forecast for chronic rhinosinusitis market?

Answer: The global chronic rhinosinusitis market is expected to grow with a CAGR of 7.5% from 2024 to 2030.

Q2. What are the major drivers influencing the growth of the chronic rhinosinusitis market?

Answer: The major drivers for this market are growing number of clinical trials, rise in the need for innovative therapeutic approaches, and ongoing technological advancements in diagnostic tools.

Q3. What are the major segments for chronic rhinosinusitis market?

Answer: The future of the chronic rhinosinusitis market looks promising with opportunities in the hospital, specialty clinic, and ambulatory surgical center markets.

Q4. Who are the key chronic rhinosinusitis market companies?

Answer: Some of the key chronic rhinosinusitis companies are as follows:

  • Lyra Therapeutics
  • Novartis
  • Medtronic
  • GlaxoSmithKline
  • AstraZeneca
  • Sanofi
  • Dr. Reddy's Laboratories
  • Stryker Corporation
  • Bayer
  • Smith & Nephew

Q5. Which chronic rhinosinusitis market segment will be the largest in future?

Answer: Lucintel forecasts that steroid nasal spray is expected to witness the highest growth over the forecast period.

Q6. In chronic rhinosinusitis market, which region is expected to be the largest in next 5 years?

Answer: North America is expected to witness the highest growth over the forecast period.

Q7. Do we receive customization in this report?

Answer: Yes, Lucintel provides 10% customization without any additional cost.

This report answers following 11 key questions:

  • Q.1. What are some of the most promising, high-growth opportunities for the chronic rhinosinusitis market by treatment type (medical devices, drugs, nasal drops, steroid nasal sprays, surgery, and others), disease phenotype (non-eosinophilic chronic rhinosinusitis, eosinophilic chronic rhinosinusitis, infectious chronic rhinosinusitis, allergic fungal rhinosinusitis, and others), end use (hospitals, specialty clinics, ambulatory surgical centers, and others), and region (North America, Europe, Asia Pacific, and the Rest of the World)?
  • Q.2. Which segments will grow at a faster pace and why?
  • Q.3. Which region will grow at a faster pace and why?
  • Q.4. What are the key factors affecting market dynamics? What are the key challenges and business risks in this market?
  • Q.5. What are the business risks and competitive threats in this market?
  • Q.6. What are the emerging trends in this market and the reasons behind them?
  • Q.7. What are some of the changing demands of customers in the market?
  • Q.8. What are the new developments in the market? Which companies are leading these developments?
  • Q.9. Who are the major players in this market? What strategic initiatives are key players pursuing for business growth?
  • Q.10. What are some of the competing products in this market and how big of a threat do they pose for loss of market share by material or product substitution?
  • Q.11. What M&A activity has occurred in the last 5 years and what has its impact been on the industry?

Table of Contents

1. Executive Summary

2. Global Chronic Rhinosinusitis Market : Market Dynamics

  • 2.1: Introduction, Background, and Classifications
  • 2.2: Supply Chain
  • 2.3: Industry Drivers and Challenges

3. Market Trends and Forecast Analysis from 2018 to 2030

  • 3.1. Macroeconomic Trends (2018-2023) and Forecast (2024-2030)
  • 3.2. Global Chronic Rhinosinusitis Market Trends (2018-2023) and Forecast (2024-2030)
  • 3.3: Global Chronic Rhinosinusitis Market by Treatment Type
    • 3.3.1: Medical Devices
    • 3.3.2: Drugs
    • 3.3.3: Nasal Drops
    • 3.3.4: Steroid Nasal Sprays
    • 3.3.5: Surgery
    • 3.3.6: Others
  • 3.4: Global Chronic Rhinosinusitis Market by Disease Phenotype
    • 3.4.1: Non-Eosinophilic Chronic Rhinosinusitis
    • 3.4.2: Eosinophilic Chronic Rhinosinusitis
    • 3.4.3: Infectious Chronic Rhinosinusitis
    • 3.4.4: Allergic Fungal Rhinosinusitis
    • 3.4.5: Others
  • 3.5: Global Chronic Rhinosinusitis Market by End Use
    • 3.5.1: Hospitals
    • 3.5.2: Specialty Clinics
    • 3.5.3: Ambulatory Surgical Centers
    • 3.5.4: Others

4. Market Trends and Forecast Analysis by Region from 2018 to 2030

  • 4.1: Global Chronic Rhinosinusitis Market by Region
  • 4.2: North American Chronic Rhinosinusitis Market
    • 4.2.1: North American Chronic Rhinosinusitis Market by Treatment Type: Medical Devices, Drugs, Nasal Drops, Steroid Nasal Sprays, Surgery, and Others
    • 4.2.2: North American Chronic Rhinosinusitis Market by End Use: Hospitals, Specialty Clinics, Ambulatory Surgical Centers, and Others
  • 4.3: European Chronic Rhinosinusitis Market
    • 4.3.1: European Chronic Rhinosinusitis Market by Treatment Type: Medical Devices, Drugs, Nasal Drops, Steroid Nasal Sprays, Surgery, and Others
    • 4.3.2: European Chronic Rhinosinusitis Market by End Use: Hospitals, Specialty Clinics, Ambulatory Surgical Centers, and Others
  • 4.4: APAC Chronic Rhinosinusitis Market
    • 4.4.1: APAC Chronic Rhinosinusitis Market by Treatment Type: Medical Devices, Drugs, Nasal Drops, Steroid Nasal Sprays, Surgery, and Others
    • 4.4.2: APAC Chronic Rhinosinusitis Market by End Use: Hospitals, Specialty Clinics, Ambulatory Surgical Centers, and Others
  • 4.5: ROW Chronic Rhinosinusitis Market
    • 4.5.1: ROW Chronic Rhinosinusitis Market by Treatment Type: Medical Devices, Drugs, Nasal Drops, Steroid Nasal Sprays, Surgery, and Others
    • 4.5.2: ROW Chronic Rhinosinusitis Market by End Use: Hospitals, Specialty Clinics, Ambulatory Surgical Centers, and Others

5. Competitor Analysis

  • 5.1: Product Portfolio Analysis
  • 5.2: Operational Integration
  • 5.3: Porter's Five Forces Analysis

6. Growth Opportunities and Strategic Analysis

  • 6.1: Growth Opportunity Analysis
    • 6.1.1: Growth Opportunities for the Global Chronic Rhinosinusitis Market by Treatment Type
    • 6.1.2: Growth Opportunities for the Global Chronic Rhinosinusitis Market by Disease Phenotype
    • 6.1.3: Growth Opportunities for the Global Chronic Rhinosinusitis Market by End Use
    • 6.1.4: Growth Opportunities for the Global Chronic Rhinosinusitis Market by Region
  • 6.2: Emerging Trends in the Global Chronic Rhinosinusitis Market
  • 6.3: Strategic Analysis
    • 6.3.1: New Product Development
    • 6.3.2: Capacity Expansion of the Global Chronic Rhinosinusitis Market
    • 6.3.3: Mergers, Acquisitions, and Joint Ventures in the Global Chronic Rhinosinusitis Market
    • 6.3.4: Certification and Licensing

7. Company Profiles of Leading Players

  • 7.1: Lyra Therapeutics
  • 7.2: Novartis
  • 7.3: Medtronic
  • 7.4: GlaxoSmithKline
  • 7.5: AstraZeneca
  • 7.6: Sanofi
  • 7.7: Dr. Reddy's Laboratories
  • 7.8: Stryker Corporation
  • 7.9: Bayer
  • 7.10: Smith & Nephew